Long noncoding RNAs (lncRNAs) and the molecular hallmarks of aging

Aging

Volumn 6, Issue 12, 2014, Pages 992-1009

  Grammatikakis, Ioannis ^a   Panda, Amaresh C ^a   Abdelmohsen, Kotb ^a   Gorospe, Myriam ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Epigenetic control by lncRNAs; LncRNA influencing aging phenotypes; LncRNA regulation of post transcriptional gene expression; Long noncoding RNAs; Senescence associated lncRNAs

Indexed keywords

CELL CYCLE PROTEIN; GENETIC MARKER; LONG UNTRANSLATED RNA;

AGE; AGING; ANIMAL; CELL AGING; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETIC MARKER; GENETICS; GENOMIC INSTABILITY; GENOTYPE; HUMAN; METABOLISM; PATHOLOGY; PHENOTYPE; STEM CELL; TELOMERE HOMEOSTASIS;

AGE FACTORS; AGING; ANIMALS; CELL AGING; CELL CYCLE PROTEINS; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION; GENETIC MARKERS; GENOMIC INSTABILITY; GENOTYPE; HUMANS; PHENOTYPE; RNA, LONG NONCODING; STEM CELLS; TELOMERE HOMEOSTASIS;

EID: 84920879801     PISSN: 19454589     EISSN: None     Source Type: Journal    
DOI: 10.18632/aging.100710     Document Type: Article

References (196)

1. López-Otin C, Blasco MA, Partridge L, Serrano M and Kroemer G. The hallmarks of aging. Cell. 2013; 153:1194-1217.
2. Rufini A, Tucci P, Celardo I and Melino G. Senescence and aging: the critical roles of p53. Oncogene. 2013; 32:5129-5143.
3. Wang WG. Regulatory RNA-binding proteins in senescence. Ageing Res Rev. 2012; 11:485-490.
4. Wu G, Wang D, Huang Y and Han JD. The research progress of microRNAs in aging. Prog Biochem Biophys. 2014; 41:273-287.
5. Yoon JH, Abdelmohsen K and Gorospe M. Posttranscriptional gene regulation by long noncoding RNA. J Mol Biol. 2013, 425:3723-3730.
6. Singh DK and Prasanth KV. Functional insights into the role of nuclear-retained long noncoding RNAs in gene expression control in mammalian cells. Chromosome Res. 2013; 21:695-711.
7. Yoon JH, Abdelmohsen K, Kim J, Yang XL, Martindale JL, Tominaga-Yamanaka K, White EJ, Orjalo AV, Rinn JL, Kreft SG, Wilson GM and Gorospe M. Scaffold function of long non-coding RNA HOTAIR in protein ubiquitination. Nat Commun. 2013; 4.
8. Kung JT, Colognori D and Lee JT. Long noncoding RNAs:past, present, and future. Genetics. 2013; 193:651-669.
9. Spitale RC, Tsai MC and Chang HY. RNA templating the epigenome Long noncoding RNAs as molecular scaffolds. Epigenetics US. 2011; 6:539-543.
10. Lee JT. Epigenetic regulation by long noncoding RNAs. Science 2012; 338:1435-1439.
11. Bergmann JH and Spector DL. Long non-coding RNAs:modulators of nuclear structure and function. Curr Opin Cell Biol. 2014; 26:10-18.
12. Gong CG and Maquat LE. lncRNAs transactivate STAU1-mediated mRNA decay by duplexing with 3 ' UTRs via Alu elements. Nature. 2011; 470:284-288.
13. Yoon JH, Abdelmohsen K, Srikantan S, Yang XL, Martindale JL, De S, Huarte M, Zhan M, Becker KG and Gorospe M. LincRNAp21 suppresses target mRNA translation. Mol Cell. 2012; 47:648-655.
14. Abdelmohsen K, Panda AC, Kang MJ, Guo R, Kim J, Grammatikakis I, Yoon JH, Dudekula DB, Noh JH, Yang X, Martindale JL and Gorospe M. 7SL RNA represses p53 translation by competing with HuR. Nucleic Acids Res. 2014; 42:10099-10111.
15. Mattick JS. Long noncoding RNAs in cell and developmental biology. Semin Cell Dev Biol. 2011; 22:327-327.
16. Anko ML and Neugebauer KM. Long noncoding RNAs add another layer to pre-mRNA splicing regulation. Mol Cell. 2010, 39:833-834.
17. Cesana M, Cacchiarelli D, Legnini I, Santini T, Sthandier O, Chinappi M, Tramontano A and Bozzoni I. A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA. Cell. 2011, 147:358-369.
18. Tay Y, Rinn J and Pandolfi PP. The multilayered complexity of ceRNA crosstalk and competition. Nature. 2014; 505:344-352.
19. Kuilman T, Michaloglou C, Mooi WJ and Peeper DS. The essence of senescence. Genes Dev. 2010; 24:2463-2479.
20. Samper E, Flores JM and Blasco MA. Restoration of telomerase activity rescues chromosomal instability and premature aging in Terc-/-mice with short telomeres. EMBO Rep. 2001; 2:800-807.
21. Collins K. Physiological assembly and activity of human telomerase complexes. Mech Ageing Dev. 2008; 129:91-98.
22. Azzalin CM, Reichenbach P, Khoriauli L, Giulotto E and Lingner J. Telomeric repeat-containing RNA and RNA surveillance factors at mammalian chromosome ends. Science. 2007; 318:798-801.
23. Porro A, Feuerhahn S and Lingner J. TERRA-reinforced association of LSD1 with MRE11 promotes processing of uncapped telomeres. Cell Rep. 2014; 6:765-776.
24. Redon S, Reichenbach P and Lingner J. The non-coding RNA TERRA is a natural ligand and direct inhibitor of human telomerase. Nucleic Acids Res. 2010; 38:5797-5806.
25. Deng Z, Campbell AE and Lieberman PM. TERRA, CpG methylation and telomere heterochromatin: lessons from ICF syndrome cells. Cell Cycle. 2010; 9:69-74.
26. Yu TY, Kao YW and Lin JJ. Telomeric transcripts stimulate telomere recombination to suppress senescence in cells lacking telomerase. Proc Natl Acad Sci USA. 2014; 111:3377-3382.
27. Flynn RL, Centore RC, O'Sullivan RJ, Rai R, Tse A, Songyang Z, Chang S, Karlseder J and Zou L. TERRA and hnRNPA1 orchestrate an RPA-to-POT1 switch on telomeric single-stranded DNA. Nature. 2011; 471:532-536.
28. Munoz-Najar U and Sedivy JM. Epigenetic control of aging. Antiox. Redox Sig. 2011; 14:241-259.
29. Pawlikowski JS, Adams PD and Nelson DM. Senescence at a glance. J Cell Sci. 2013; 126:4061-4067.
30. Johnson AA, Akman K, Calimport SR, Wuttke D, Stolzing A and de Magalhaes JP. The role of DNA methylation in aging, rejuvenation, and age-related disease. Rejuv Res. 2012; 15:483-494.
31. Maegawa S, Hinkal G, Kim HS, Shen L, Zhang L, Zhang J, Zhang N, Liang S, Donehower LA and Issa JP. Widespread and tissue specific age-related DNA methylation changes in mice. Genome Res. 2010; 20:332-340.
32. Umlauf D, Fraser P and Nagano T. The role of long noncoding RNAs in chromatin structure and gene regulation:variations on a theme. Biol Chem. 2008; 389:323-331.
33. Sado T and Brockdorff N. Advances in understanding chromosome silencing by the long non-coding RNA Xist. Philos Trans R Soc Lond B Biol Sci. 2013; 368:20110325.
34. Abdelmohsen K, Panda A, Kang MJ, Xu J, Selimyan R, Yoon JH, Martindale JL, De S, Wood WH 3rd, Becker KG and Gorospe M. Senescence-associated lncRNAs:senescence-associated long noncoding RNAs. Aging Cell. 2013; 12:890-900.
35. Ratajczak MZ. Igf2-H19, an imprinted tandem gene, is an important regulator of embryonic development, a guardian of proliferation of adult pluripotent stem cells, a regulator of longevity, and a 'passkey' to cancerogenesis. Folia Histochem Cyto. 2012; 50:171-179.
36. Monnier P, Martinet C, Pontis J, Stancheva I, Ait-Si-Ali S and Dandolo L. H19 lncRNA controls gene expression of the Imprinted Gene Network by recruiting MBD1. Proc Natl Acad Sci USA. 2013; 110:20693-20698.
37. Thorvaldsen JL, Duran KL and Bartolomei MS. Deletion of the H19 differentially methylated domain results in loss of imprinted expression of H19 and Igf2. Genes Dev. 1998; 12:3693-3702.
38. Gabory A, Jammes H and Dandolo L. The H19 locus:Role of an imprinted non-coding RNA in growth and development. Bioessays. 2010; 32:473-480.
39. Matouk I, DeGroot N, Mezan S, Galun E and Hochberg A. The H19 non-coding RNA is essential for human tumor growth and may serve as an anti-tumor target. Hum Gene Ther. 2007; 18:1034-1034.
40. Issa JPJ, Vertino PM, Boehm CD, Newsham IF and Baylin SB. Switch from monoallelic to biallelic human IGF2 promoter methylation during aging and carcinogenesis. Proc Natl Acad Sci USA. 1996; 93:11757-11762.
41. Fu VX, Dobosy JR, Desotelle JA, Almassi N, Ewald JA, Srinivasan R, Berres M, Svaren J, Weindruch R and Jarrard DF. Aging and cancer-related loss of insulin-like growth factor 2 imprinting in the mouse and human prostate. Cancer Res. 2008; 68:6797-6802.
42. Christofori G, Naik P and Hanahan D. A second signal supplied by insulin-like growth factor II in oncogene-induced tumorigenesis. Nature. 1994; 369:414-418.
43. Travers ME, Mackay DJ, Dekker Nitert M, Morris AP, Lindgren CM, Berry A, Johnson PR, Hanley N, Groop LC, McCarthy MI and Gloyn AL. Insights into the molecular mechanism for type 2 diabetes susceptibility at the KCNQ1 locus from temporal changes in imprinting status in human islets. Diabetes. 2013; 62:987-992.
44. Sazhenova EA and Lebedev IN. Epimutations of the KCNQ1OT1 imprinting center of chromosome 11 in early human embryo lethality. Genetika. 2008; 44:1609-1616.
45. Latos PA, Pauler FM, Koerner MV, Senergin HB, Hudson QJ, Stocsits RR, Allhoff W, Stricker SH, Klement RM, Warczok KE, Aumayr K, Pasierbek P and Barlow DP. Airn transcriptional overlap, but not its lncRNA products, induces imprinted Igf2r silencing. Science. 2012; 338:1469-1472.
46. Xu W, Zhuang ZX, Yang JP, Yang LQ, Xu YL, Zhang WJ and Zeng Y. The profile of IGF2R gene expression and H3 histone modifications in replicative cell senescence. J Sichuan Univ Med Sci. 2014; 45:6-9.
47. Abdul Rahman A, Abdul Karim N, Abdul Hamid NA, Harun R and Ngah WZ. Senescence-related changes in gene expression of peripheral blood mononuclear cells from octo/nonagenarians compared to their offspring. Oxid Med Cell Longev. 2013; 189129.
48. Di Ruscio A, Ebralidze AK, Benoukraf T, Amabile G, Goff LA, Terragni J, Figueroa ME, De Figueiredo Pontes LL, Alberich-Jorda M, Zhang P, Wu M, D'Alò F, Melnick A, et al. DNMT1-interacting RNAs block gene-specific DNA methylation. Nature. 2013; 503:371-376.
49. Wang HM, Iakova P, Wilde M, Welm A, Goode T, Roesler WJ and Timchenko NA. C/EBP alpha arrests cell proliferation through direct inhibition of cdk2 and cdk4. Mol Cell. 2001; 8:817-828.
50. Karagiannides I, Tchkonia T, Dobson DE, Steppan CM, Cummins P, Chan G, Salvatori K, Hadzopoulou-Cladaras M and Kirkland JL. Altered expression of C/EBP family members results in decreased adipogenesis with aging. Am J Physiol. 2001; 280:R1772-R1780.
51. Hong IH, Lewis K, Iakova P, Jin JL, Sullivan E, Jawanmardi N, Timchenko L and Timchenko N. Age-associated change of C/EBP family proteins causes severe liver injury and acceleration of liver proliferation after CCl4 treatments. J Biol Chem. 2014; 289:1106-1118.
52. Huggins CJ, Malik R, Lee S, Salotti J, Thomas S, Martin N, Quiñones OA, Alvord WG, Olanich ME, Keller JR and Johnson PF. C/EBP gamma suppresses senescence and inflammatory gene expression by heterodimerizing with C/EBP beta. Mol Cell Biol. 2013; 33:3242-3258.
53. Schmitz KM, Mayer C, Postepska A and Grummt I. Interaction of noncoding RNA with the rDNA promoter mediates recruitment of DNMT3b and silencing of rRNA genes. Genes Dev. 2010; 24:2264-2269.
54. Machwe A, Orren DK and Bohr VA. Accelerated methylation of ribosomal RNA genes during the cellular senescence of Werner syndrome fibroblasts. FASEB J. 2000; 14:1715-1724.
55. Johnson R and Strehler BL. Loss of genes coding for ribosomal-RNA in aging brain cells. Nature. 1972; 240:412-414.
56. Pietrzak M, Rempala G, Nelson PT, Zheng JJ and Hetman M. Epigenetic silencing of nucleolar rRNA genes in Alzheimer's disease. PLoS ONE. 2011; 6:e22585.
57. Bierhoff H, Schmitz K, Maass F, Ye J and Grummt I. Noncoding transcripts in sense and antisense orientation regulate the epigenetic state of ribosomal RNA genes. Cold Spring Harbor Symp Quant Biol. 2010; 75:357-364
58. Bierhoff H, Dammert MA, Brocks D, Dambacher S, Schotta G and Grummt I. Quiescence-induced LncRNAs trigger H4K20 trimethylation and transcriptional silencing. Mol Cell. 2014; 54:675-682.
59. Johnsson P, Ackley A, Vidarsdottir L, Lui WO, Corcoran M, Grander D and Morris KV. A pseudogene long-noncoding-RNA network regulates PTEN transcription and translation in human cells. Nat Struct Mol Biol. 2013; 20:440-446
60. Kitagishi Y and Matsuda S. Redox regulation of tumor suppressor PTEN in cancer and aging. Intl J Mol Med 2013; 31:511-515.
61. Ortega-Molina A and Serrano M. PTEN in cancer, metabolism, and aging. Trends Endoncrinol Metab. 2013; 24:184-189.
62. Tarnawski AS, Pai R, Tanigawa T, Matysiak-Budnik T and Ahluwalia A. PTEN silencing reverses aging-related impairment of angiogenesis in microvascular endothelial cells. Biochem Biophys Res Commun. 2010; 394:291-296.
63. Moon SH, Kim DK, Cha Y, Jeon I, Song J and Park KS. PI3K/Akt and Stat3 signaling regulated by PTEN control of the cancer stem cell population, proliferation and senescence in a glioblastoma cell line. Intl J Oncol. 2013; 42:921-928.
64. Collado M. Exploring a 'pro-senescence' approach for prostate cancer therapy by targeting PTEN. Future Oncol. 2010; 6:687-689.
65. Arab K, Park YJ, Lindroth AM, Schafer A, Oakes C, Weichenhan D, Lukanova A, Lundin E, Risch A, Meister M, Dienemann H, Dyckhoff G, Herold-Mende C, et al. Long noncoding RNA TARID directs demethylation and activation of the tumor suppressor TCF21 via GADD45A. Mol Cell. 2014; 55:604-614.
66. D'Aquila P, Rose G, Bellizzi D and Passarino G. Epigenetics and aging. Maturitas. 2013; 74:130-136.
67. Zhang W, Hu D, Ji W, Yang L, Yang J, Yuan J, Xuan A, Zou F and Zhuang Z. Histone modifications contribute to cellular replicative and hydrogen peroxide-induced premature senescence in human embryonic lung fibroblasts. Free Rad Res. 2014; 48:550-559.
68. Han S and Brunet A. Histone methylation makes its mark on longevity. Trends Cell Biol. 2012; 22:42-49.
69. Fraga MF and Esteller M. Epigenetics and aging:the targets and the marks. Trends Genet. 2007; 23:413-418.
70. Jin C, Li J, Green CD, Yu X, Tang X, Han D, Xian B, Wang D, Huang X, Cao X, Yan Z, Hou L, Liu J, et al. Histone demethylase UTX-1 regulates C. elegans life span by targeting the insulin/IGF-1 signaling pathway. Cell Metab. 2011; 14:161-172.
71. Greer EL, Maures TJ, Hauswirth AG, Green EM, Leeman DS, Maro GS, Han S, Banko MR and Gozani O, Brunet. Members of the H3K4 trimethylation complex regulate lifespan in a germlinedependent manner in C. elegans. Nature. 2010; 466:383-U137.
72. Siebold AP, Banerjee R, Tie F, Kiss DL, Moskowitz J and Harte PJ. Polycomb Repressive Complex 2 and Trithorax modulate Drosophila longevity and stress resistance. Proc Natl Acad Sci USA. 2010; 107:169-174.
73. Moric-Janiszewska E, Glogowska-Ligus J, Paul-Samojedny M, Weglarz L, Markiewicz-Loskot G and Szydlowski L. Age-and sexdependent mRNA expression of KCNQ1 and HERG in patients with long QT syndrome type 1 and 2. Arch Med Sci AMS. 2011; 7:941-947.
74. Korostowski L, Sedlak N and Engel N. The Kcnq1ot1 long noncoding RNA affects chromatin conformation and expression of Kcnq1, but does not regulate its imprinting in the developing heart. PLoS Genet. 2012; 8:e1002956.
75. Pandey RR, Mondal T, Mohammad F, Enroth S, Redrup L, Komorowski J, Nagano T, Mancini-Dinardo D, Kanduri C et al. Kcnq1ot1 antisense noncoding RNA mediates lineage-specific transcriptional silencing through chromatin-level regulation. Mol Cell. 2008; 32:232-246.
76. Gomez JA, Wapinski OL, Yang YW, Bureau JF, Gopinath S, Monack DM, Chang HY, Brahic M and Kirkegaard K. The NeST long ncRNA controls microbial susceptibility and epigenetic activation of the interferon-gamma locus. Cell. 2013; 152:743-754.
77. Yap KL, Li S, Munoz-Cabello AM, Raguz S, Zeng L, Mujtaba S, Gil J, Walsh MJ and Zhou MM. Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a. Mol Cell. 2010; 38:662-674.
78. Kim DH, Kim JS, Ji YI, Shim YM, Kim H, Han J and Park J. Hypermethylation of RASSF1A promoter is associated with the age at starting smoking and a poor prognosis in primary nonsmall cell lung cancer. Cancer Res. 2003; 63:3743-3746.
79. Beckedorff FC, Ayupe AC, Crocci-Souza R, Amaral MS, Nakaya HI, Soltys DT, Menck CF, Reis EM and Verjovski-Almeida S. The Intronic long noncoding RNA ANRASSF1 recruits PRC2 to the RASSF1A promoter, reducing the expression of RASSF1A and increasing cell proliferation. PLoS Genet. 2013;9(8):e1003705.
80. Marin-Bejar O, Marchese FP, Athie A, Sanchez Y, Gonzalez J, Segura V, Huang L, Moreno I, Navarro A, Monzó M, García-Foncillas J, Rinn JL, Guo S, et al. Pint lincRNA connects the p53 pathway with epigenetic silencing by the Polycomb repressive complex 2. Genome Biol 2013; 14-9-r104.
81. Krieglstein K, Miyazono K, ten Dijke P and Unsicker K. TGFbeta in aging and disease. Cell Tissue Res. 2012; 347:5-9.
82. Williamson D, Gallagher P, Harber M, Hollon C and Trappe S. Mitogen-activated protein kinase (MAPK) pathway activation:effects of age and acute exercise on human skeletal muscle. J Phsyiol. 2003; 547:977-987.
83. Narita M, Narita M, Krizhanovsky V, Nunez S, Chicas A, Hearn SA, Myers MP and Lowe SW. A novel role for high-mobility group a proteins in cellular senescence and heterochromatin formation. Cell. 2006; 126:503-514.
84. Zhang R, Poustovoitov MV, Ye X, Santos HA, Chen W, Daganzo SM, Erzberger JP, Serebriiskii IG, Canutescu AA, Dunbrack RL, Pehrson JR, Berger JM, Kaufman PD and Adams PD. Formation of MacroH2A-containing senescence-associated heterochromatin foci and senescence driven by ASF1a and HIRA. Dev Cell. 2005; 8:19-30.
85. Tsurumi A and Li WX. Global heterochromatin loss: a unifying theory of aging? Epigenetics. 2012; 7:680-688.
86. Oberdoerffer P and Sinclair DA. The role of nuclear architecture in genomic instability and ageing. Nat Rev Mol Cell Biol. 2007; 8:692-702.
87. Larson K, Yan SJ, Tsurumi A, Liu J, Zhou J, Gaur K, Guo D, Eickbush TH and Li WX. Heterochromatin formation promotes longevity and represses ribosomal RNA synthesis. PLoS Genet. 2012; 8:e1002473.
88. Schotta G, Lachner M, Sarma K, Ebert A, Sengupta R, Reuter G, Reinberg D and Jenuwein T. A silencing pathway to induce H3-K9 and H4-K20 trimethylation at constitutive heterochromatin. Genes Dev. 2004; 18:1251-1262.
89. Deng Z, Norseen J, Wiedmer A, Riethman H and Lieberman PM. TERRA RNA binding to TRF2 facilitates heterochromatin formation and ORC recruitment at telomeres. Mol Cell. 2009; 35:403-413.
90. Keller C, Kulasegaran-Shylini R, Shimada Y, Hotz HR and Buhler M. Noncoding RNAs prevent spreading of a repressive histone mark. Nat Struct Mol Biol. 2013; 20:994-1000.
91. Anderson RM. A Role for Dicer in Aging and Stress Survival. Cell Metab. 2012; 16:285-286.
92. Srikantan S, Marasa BS, Becker KG, Gorospe M and Abdelmohsen K. Paradoxical microRNAs Individual gene repressors, global translation enhancers. Cell Cycle. 2011; 10:751-759.
93. Powers ET, Morimoto RI, Dillin A, Kelly JW and Balch WE. Biological and chemical approaches to diseases of proteostasis deficiency. Annual Rev Biochem. 2009; 78:959-991.
94. Balch WE, Morimoto RI, Dillin A and Kelly JW. Adapting proteostasis for disease intervention. Science. 2008; 319:916-919.
95. Rubinsztein DC, Marino G and Kroemer G. Autophagy and aging. Cell 2011; 146:682-695.
96. Gewirtz DA. Autophagy and senescence:a partnership in search of definition. Autophagy. 2013; 9:808-812.
97. Zhao Y, Guo Q, Chen J, Hu J, Wang S and Sun Y. Role of long non-coding RNA HULC in cell proliferation, apoptosis and tumor metastasis of gastric cancer:a clinical and in vitro investigation. Oncology Rep. 2014; 31:358-364.
98. Zhang Q, Su M, Lu G and Wang J. The complexity of bladder cancer:long noncoding RNAs are on the stage. Mol Cancer. 2013; 12:101.
99. Ying L, Huang Y, Chen H, Wang Y, Xia L, Chen Y, Liu Y and Qiu F. Downregulated MEG3 activates autophagy and increases cell proliferation in bladder cancer. Mol Biosystems. 2013; 9:407-411.
100. Baldassarre A and Masotti A. Long Non-Coding RNAs and p53 Regulation. Intl J Mol Sci. 2012; 13:16708-16717.
101. Tasdemir E, Maiuri MC, Morselli E, Criollo A, D'Amelio M, Djavaheri-Mergny M, Cecconi F, Tavernarakis N and Kroemer G. A dual role of p53 in the control of autophagy. Autophagy. 2008; 4:810-814.
102. Mourtada-Maarabouni M, Pickard MR, Hedge VL, Farzaneh F and Williams GT. GAS5, a non-protein-coding RNA, controls apoptosis and is downregulated in breast cancer. Oncogene. 2009; 28:195-208.
103. Lee SY, Hwang YK, Yun HS and Han JS. Decreased levels of nuclear glucocorticoid receptor protein in the hippocampus of aged Long-Evans rats with cognitive impairment. Brain Res. 2012; 1478:48-54.
104. Di Agostino S, Strano S, Emiliozzi V, Zerbini V, Mottolese F, Sacchi A, Blandino G and Piaggio G. Gain of function of mutant p53: The mutant p53/NF-Y protein complex reveals an aberrant transcriptional mechanism of cell cycle regulation. Cancer Cell. 2006; 10:191-202.
105. Matuoka K and Chen KY. Possible role of subunit A of nuclear factor Y (NF-YA) in normal human diploid fibroblasts during senescence. Biogerontol. 2000; 1:261-271.
106. Hollander MC, Alamo I and Fornace AJ Jr. A novel DNA damage-inducible transcript, gadd7, inhibits cell growth, but lacks a protein product. Nucleic Acids Res. 1996; 24:1589-1593.
107. Liu X, Li D, Zhang W, Guo M and Zhan Q. Long non-coding RNA gadd7 interacts with TDP-43 and regulates Cdk6 mRNA decay. EMBO J. 2012; 31:4415-4427.
108. Rader J, Russell MR, Hart LS, Nakazawa MS, Belcastro LT, Martinez D, Li Y, Carpenter EL, Attiyeh EF, Diskin SJ, Kim S, Parasuraman S, Caponigro G et al. Dual CDK4/CDK6 inhibition induces cell-cycle arrest and senescence in neuroblastoma. Clin Cancer Res. 2013; 19:6173-6182.
109. Wang Y, Xu Z, Jiang J, Xu C, Kang J, Xiao L, Guo X and Liu H. Endogenous miRNA sponge lincRNA-RoR regulates Oct4, Nanog, and Sox2 in human embryonic stem cell self-renewal. Dev Cell. 2013; 25:69-80.
110. Carrieri C, Cimatti L, Biagioli M, Beugnet A, Zucchelli S, Fedele S, Pesce E, Ferrer I, Collavin L, Santoro C, Forrest AR, Carninci P, Biffo S, et al. Long non-coding antisense RNA controls Uchl1 translation through an embedded SINEB2 repeat. Nature. 2012; 491:454-457.
111. Maraganore DM, Lesnick TG, Elbaz A, Chartier-Harlin MC, Gasser T, Kruger R, Hattori N, Mellick GD, Quattrone A, Satoh J, Toda T, Wang J, Ioannidis JP, de Andrade M, et al. UCHL1 is a Parkinson's disease susceptibility gene. Annals Neurol. 2004; 55:512-521.
112. Ummanni R, Jost E, Braig M, Lohmann F, Mundt F, Barett C, Schlomm T, Sauter G, Senff T, Bokemeyer C, Sültmann H, Meyer-Schwesinger C, Brümmendorf TH, et al. Ubiquitin carboxylterminal hydrolase 1 (UCHL1) is a potential tumour suppressor in prostate cancer and is frequently silenced by promoter methylation. Mol Cancer. 2011; 1476-4598-10-129.
113. Konishi N, Shimada K, Nakamura M, Ishida E, Ota I, Tanaka N and Fujimoto K. Function of junB in transient amplifying cell senescence and progression of human prostate cancer. Clin Cancer Res. 2008; 14:4408-4416.
114. Marchand A, Atassi F, Gaaya A, Leprince P, Le Feuvre C, Soubrier F, Lompré AM and Nadaud S. The Wnt/beta-catenin pathway is activated during advanced arterial aging in humans. Aging Cell. 2011; 10:220-232.
115. Ye XF, Zerlanko B, Kennedy A, Banumathy G, Zhang RG and Adams PD. Downregulation of Wnt signaling is a trigger for formation of facultative heterochromatin and onset of cell senescence in primary human cells. Mol Cell. 2007; 27:183-196.
116. Xu M, Yu Q, Subrahmanyam R, Difilippantonio MJ, Ried T and Sen JM. beta-catenin expression results in p53-independent DNA damage and oncogene-induced senescence in prelymphomagenic thymocytes in vivo. Mol Cell Biol. 2008; 28:1713-1723.
117. Lustig AJ. Telomerase RNA:a flexible RNA scaffold for telomerase biosynthesis. Curr Biol. 2004; 14:R565-567.
118. Greider CW and Blackburn EH. A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis. Nature. 1989; 337:331-337.
119. Kurokawa R. Promoter-associated long noncoding RNAs repress transcription through a RNA binding protein TLS. Adv Exp Med Biol. 2011; 722:196-208.
120. Li Z, Chao TC, Chang KY, Lin N, Patil VS, Shimizu C, Head SR, Burns JC and Rana TM. The long noncoding RNA THRIL regulates TNFalpha expression through its interaction with hnRNPL. Proc Natl Acad Sci USA. 2014; 111:1002-1007.
121. Li YQ. Master stem cell transcription factors and signaling regulation. Cellular Reprog. 2010; 12:3-13.
122. Boyer LA, Plath K, Zeitlinger J, Brambrink T, Medeiros LA, Lee TI, Levine SS, Wernig M, Tajonar A, Ray MK, Bell GW, Otte AP, Vidal M, et al. Polycomb complexes repress developmental regulators in murine embryonic stem cells. Nature. 2006; 441:349-353.
123. Sheik Mohamed J, Gaughwin PM, Lim B, Robson P and Lipovich L. Conserved long noncoding RNAs transcriptionally regulated by Oct4 and Nanog modulate pluripotency in mouse embryonic stem cells. RNA. 2010; 16:324-337.
124. Guttman M, Donaghey J, Carey BW, Garber M, Grenier JK, Munson G, Young G, Lucas AB, Ach R, Bruhn L, Yang X, Amit I, Meissner A, et al. lincRNAs act in the circuitry controlling pluripotency and differentiation. Nature. 2011; 477:295-300.
125. Ballas N, Grunseich C, Lu DD, Speh JC and Mandel G. REST and its corepressors mediate plasticity of neuronal gene chromatin throughout neurogenesis. Cell. 2005; 121:645-657.
126. Cai L, Bian M, Liu M, Sheng Z, Suo H, Wang Z, Huang F and Fei J. Ethanol-induced neurodegeneration in NRSF/REST neuronal conditional knockout mice. Neurosci. 2011; 181:196-205.
127. Whalley K. Neurodegeneration:Ageing neurons need REST. Nat Rev Neurosci. 2014; 15:279.
128. Johnson R, Teh CH, Jia H, Vanisri RR, Pandey T, Lu ZH, Buckley NJ, Stanton LW and Lipovich L. Regulation of neural macroRNAs by the transcriptional repressor REST. RNA. 2009; 15:85-96.
129. Ng SY, Johnson R and Stanton LW. Human long non-coding RNAs promote pluripotency and neuronal differentiation by association with chromatin modifiers and transcription factors. EMBO J. 2012; 31:522-533.
130. Loewer S, Cabili MN, Guttman M, Loh YH, Thomas K, Park IH, Garber M, Curran M, Onder T, Agarwal S, Manos PD, Datta S, Lander ES, et al. Large intergenic non-coding RNA-RoR modulates reprogramming of human induced pluripotent stem cells. Nat Genet. 2010; 42:1113-1117.
131. Cheng EC and Lin H. Repressing the repressor:a lincRNA as a MicroRNA sponge in embryonic stem cell self-renewal. Dev Cell. 2013; 25:1-2
132. Zhang A, Zhou N, Huang J, Liu Q, Fukuda K, Ma D, Lu Z, Bai C, Watabe K and Mo YY. The human long non-coding RNA-RoR is a p53 repressor in response to DNA damage. Cell Res. 2013; 23:340-350.
133. Dinger ME, Amaral PP, Mercer TR, Pang KC, Bruce SJ, Gardiner BB, Askarian-Amiri ME, Ru K, Soldà G, Simons C, Sunkin SM, Crowe ML, Grimmond SM, Perkins AC, et al. Long noncoding RNAs in mouse embryonic stem cell pluripotency and differentiation. Genome Res. 2008; 18:1433-1445.
134. Wu SC, Kallin EM and Zhang Y. Role of H3K27 methylation in the regulation of lncRNA expression. Cell Res. 2010; 20:1109-1116.
135. van Deursen JM. The role of senescent cells in ageing. Nature. 2014; 509:439-446.
136. Mao Z, Ke Z, Gorbunova V and Seluanov A. Replicatively senescent cells are arrested in G1 and G2 phases. Aging. 2012; 4:431-435.
137. Zender L and Rudolph KL. Keeping your senescent cells under control. Aging. 2009; 1:438-441.
138. Chen JH, Hales CN and Ozanne SE. DNA damage, cellular senescence and organismal ageing:causal or correlative? Nucleic Acids Res. 2007; 35:7417-7428.
139. Guo F, Li Y, Liu Y, Wang J, Li Y and Li G. Inhibition of metastasis-associated lung adenocarcinoma transcript 1 in CaSki human cervical cancer cells suppresses cell proliferation and invasion. Acta Biochim Biophys Sinica. 2010; 42:224-229.
140. Zhao Z, Chen C, Liu Y and Wu C. 17beta-Estradiol treatment inhibits breast cell proliferation, migration and invasion by decreasing MALAT-1 RNA level. Bioch Biphys Res Commun. 2014; 7;445:388-93.
141. Tripathi V, Shen Z, Chakraborty A, Giri S, Freier SM, Wu X, Wu X, Zhang Y, Gorospe M, Prasanth SG, Lal A and Prasanth KV. Long noncoding RNA MALAT1 controls cell cycle progression by regulating the expression of oncogenic transcription factor BMYB. PLoS Genet. 2013; 9:e1003368.
142. Eissmann M, Gutschner T, Hammerle M, Gunther S, Caudron-Herger M, Gross M, Schirmacher P, Rippe K, Braun T, Zörnig M and Diederichs S. Loss of the abundant nuclear noncoding RNA MALAT1 is compatible with life and development. RNA Biol. 2012; 9:1076-1087.
143. Pasmant E, Laurendeau I, Heron D, Vidaud M, Vidaud D and Bieche I. Characterization of a germ-line deletion, including the entire INK4/ARF locus, in a melanoma-neural system tumor family:Identification of ANRIL, an antisense noncoding RNA whose expression coclusters with ARF. Cancer Res. 2007; 67:3963-3969.
144. Kotake Y, Nakagawa T, Kitagawa K, Suzuki S, Liu N, Kitagawa M and Xiong Y. Long non-coding RNA ANRIL is required for the PRC2 recruitment to and silencing of p15(INK4B) tumor suppressor gene. Oncogene. 2011; 30:1956-1962.
145. Wang X, Arai S, Song X, Reichart D, Du K, Pascual G, Tempst P, Rosenfeld MG, Glass CK and Kurokawa R. Induced ncRNAs allosterically modify RNA-binding proteins in cis to inhibit transcription. Nature. 2008; 454:126-130.
146. Hube F, Velasco G, Rollin J, Furling D and Francastel C. Steroid receptor RNA activator protein binds to and counteracts SRA RNA-mediated activation of MyoD and muscle differentiation. Nucleic Acids Res. 2011; 39:513-525.
147. Xu B, Gerin I, Miao H, Vu-Phan D, Johnson CN, Xu R, Chen XW, Cawthorn WP, MacDougald OA and Koenig RJ. Multiple roles for the non-coding RNA SRA in regulation of adipogenesis and insulin sensitivity. PLoS ONE. 2010; 5(12):e14199.
148. Lanz RB, Chua SS, Barron N, Soder BM, DeMayo F and O'Malley BW. Steroid receptor RNA activator stimulates proliferation as well as apoptosis in vivo. Mol Cell Biol. 2003; 23:7163-7176.
149. Yang F, Zhang L, Huo XS, Yuan JH, Xu D, Yuan SX, Zhu N, Zhou WP, Yang GS, Wang YZ, Shang JL, Gao CF, Zhang FR, et al. Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humans. Hepatol. 2011; 54:1679-1689.
150. Matouk IJ, Abbasi I, Hochberg A, Galun E, Dweik H and Akkawi M. Highly upregulated in liver cancer noncoding RNA is overexpressed in hepatic colorectal metastasis. Eur J Gastroen Hepat. 2009; 21:688-692.
151. Panzitt K, Tschernatsch MMO, Guelly C, Moustafa T, Stradner M, Strohmaier HM, Buck CR, Denk H, Schroeder R, Trauner M and Zatloukal K. Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA. Gastroenterol. 2007; 132:330-342.
152. Du Y, Kong G, You X, Zhang S, Zhang T, Gao Y, Ye L and Zhang X. Elevation of highly up-regulated in liver cancer (HULC) by hepatitis B virus X protein promotes hepatoma cell proliferation via down-regulating p18. J Biol Chem. 2012; 287:26302-26311.
153. Bai F, Pei XH, Pandolfi PP and Xiong Y. p18 Ink4c and Pten constrain a positive regulatory loop between cell growth and cell cycle control. Mol Cell Biol. 2006; 26:4564-4576.
154. Ruas M, Gregory F, Jones R, Poolman R, Starborg M, Rowe J, Brookes S and Peters G. CDK4 and CDK6 delay senescence by kinase-dependent and p16INK4a-independent mechanisms. Mol Cell Biol. 2007; 27:4273-4282.
155. Wang XS, Zhang Z, Wang HC, Cai JL, Xu QW, Li MQ, Chen YC, Qian XP, Lu TJ, Yu LZ, Zhang Y, Xin DQ, Na YQ, et al. Rapid identification of UCA1 as a very sensitive and specific unique marker for human bladder carcinoma. Clin Cancer Res. 2006; 12:4851-4858.
156. Huang J, Zhou N, Watabe K, Lu Z, Wu F, Xu M and Mo YY. Long non-coding RNA UCA1 promotes breast tumor growth by suppression of p27 (Kip1). Cell Death Dis. 2014; 5:e1008.
157. Park SH, Lim JS and Jang KL. All-trans retinoic acid induces cellular senescence via upregulation of p16, p21, and p27. Cancer Lett. 2011; 310:232-239.
158. Banerji J, Rusconi S and Schaffner W. Expression of a Beta-Globin Gene Is Enhanced by Remote Sv40 DNA-Sequences. Cell. 1981; 27:299-308.
159. Geyer PK, Green MM and Gorces VG. Tissue-specific transcriptional enhancers may act in trans on the gene located in the homologous chromosome: the molecular basis of transvection in Drosophila. EMBO J. 1990; 9:2247-2256.
160. Sakabe NJ, Savic D and Nobrega MA. Transcriptional enhancers in development and disease. Genome Biol. 2012; 13:238.
161. Melo CA, Drost J, Wijchers PJ, van de Werken H, de Wit E, Oude Vrielink JA, Elkon R, Melo SA, Léveillé N, Kalluri R, de Laat W and Agami R. eRNAs are required for p53-dependent enhancer activity and gene transcription. Mol Cell. 2013; 49:524-535.
162. Barsyte-Lovejoy D, Lau SK, BoutroS PC, Khosravi F, Jurisica I, Andrulis IL, Tsao MS and Penn LZ. The c-Myc oncogene directly induces the H19 noncoding RNA by allele-specific binding to potentiate tumorigenesis. Cancer Res. 2006; 66:5330-5337.
163. Matouk IJ, DeGroot N, Mezan S, Ayesh S, Abu-Iail R, Hochberg A and Galun E. The H19 Non-Coding RNA Is Essential for Human Tumor Growth. PLoS ONE. 2007; 2(9):e845.
164. Worster DT, Schmelzle T, Solimini NL, Lightcap ES, Millard B, Mills GB, Brugge JS and Albeck JG. Akt and ERK control the proliferative response of mammary epithelial cells to the growth factors IGF-1 and EGF through the cell cycle inhibitor p57Kip2. Sci Signal. 2012; 5:ra19.
165. Joaquin M, Gubern A, Gonzalez-Nunez D, Josue Ruiz E, Ferreiro I, de Nadal E, Nebreda AR and Posas F. The p57 CDKi integrates stress signals into cell-cycle progression to promote cell survival upon stress. EMBO J. 2012; 31:2952-2964.
166. Rosenberg E, Demopoulos RI, Zeleniuch-Jacquotte A, Yee H, Sorich J, Speyer JL and Newcomb EW. Expression of cell cycle regulators p57(KIP2), cyclin D1, and cyclin E in epithelial ovarian tumors and survival. Hum Pathol. 2001; 32:808-813.
167. Li G, Domenico J, Lucas JJ and Gelfand EW. Identification of multiple cell cycle regulatory functions of p57Kip2 in human T lymphocytes. J Immunol. 2004; 173:2383-2391.
168. Zhang X, Zhou Y, Mehta KR, Danila DC, Scolavino S, Johnson SR and Klibanski A. A pituitary-derived MEG3 isoform functions as a growth suppressor in tumor cells. J Clin Endocrinol Metab. 2003; 88:5119-5126.
169. Zhou Y, Zhang X and Klibanski A. MEG3 noncoding RNA:a tumor suppressor. J Mol Endocrinol. 2012; 48:R45-53.
170. Qin R, Chen Z, Ding Y, Hao J, Hu J and Guo F. Long noncoding RNA MEG3 inhibits the proliferation of cervical carcinoma cells through the induction of cell cycle arrest and apoptosis. Neoplasma. 2013; 60:486-492.
171. Hardy K, Mansfield L, Mackay A, Benvenuti S, Ismail S, Arora P, O'Hare MJ and Jat PS. Transcriptional networks and cellular senescence in human mammary fibroblasts. Mol Biol Cell 2005; 16:943-953.
172. Chen W, Bocker W, Brosius J and Tiedge H. Expression of neural BC200 RNA in human tumours. J Pathol. 1997; 183:345-351.
173. Xu D and Tahara H. The role of exosomes and microRNAs in senescence and aging. Adv Drug Deliv Rev. 2013; 65:368-375.
174. Salminen A, Kaarniranta K and Kauppinen A. Inflammaging:disturbed interplay between autophagy and inflammasomes. Aging. 2012; 4:166-175.
175. Coppe JP, Patil CK, Rodier F, Sun Y, Munoz DP, Goldstein J, Nelson PS, Desprez PY and Campisi J. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biology. 2008; 6:2853-2868.
176. Massone S, Vassallo I, Fiorino G, Castelnuovo M, Barbieri F, Borghi R, Tabaton M, Robello M, Gatta E, Russo C, Florio T, Dieci G, Cancedda R, et al. 17A, a novel non-coding RNA, regulates GABA B alternative splicing and signaling in response to inflammatory stimuli and in Alzheimer disease. Neurobiol Dis. 2011; 41:308-317.
177. Alemany R, Perona JS, Sanchez-Dominguez JM, Montero E, Canizares J, Bressani R, Escribá PV and Ruiz-Gutierrez V. G protein-coupled receptor systems and their lipid environment in health disorders during aging. Biochim Biophys Acta. 2007; 1768:964-975.
178. Rapicavoli NA, Qu K, Zhang J, Mikhail M, Laberge RM and Chang HY. A mammalian pseudogene lncRNA at the interface of inflammation and anti-inflammatory therapeutics. eLife. 2013; 2:e00762.
179. Ratliff M, Alter S, Frasca D, Blomberg BB and Riley RL. In senescence, age-associated B cells secrete TNFalpha and inhibit survival of B-cell precursors. Aging Cell. 2013; 12:303-311.
180. Cui H, Xie N, Tan Z, Banerjee S, Thannickal VJ, Abraham E and Liu G. The human long noncoding RNA, lnc-IL7R, regulates inflammatory response. Eur J Immunol. 2014; 44:2085-95.
181. Freund A, Orjalo AV, Desprez PY and Campisi J. Inflammatory networks during cellular senescence:causes and consequences. Trends Mol Med. 2010; 16:238-246.
182. Jenny NS. Inflammation in aging:cause, effect, or both? Discovery medicine. 2012; 13:451-460.
183. Dunston CR and Griffiths HR. The effect of ageing on macrophage Toll-like receptor-mediated responses in the fight against pathogens. Clin Exp Immunol. 2010; 161:407-416.
184. Liu Y, Ferguson JF, Xue C, Ballantyne RL, Silverman IM, Gosai SJ, Serfecz J, Morley MP, Gregory BD, Li M and Reilly MP. Tissue-Specific RNA-Seq in Human Evoked Inflammation Identifies Blood and Adipose LincRNA Signatures of Cardiometabolic Diseases. Arterioscler Thromb Vasc Biol. 2014; 34:902-912.
185. Graf K and Schaefer-Graf UM. Is Smad3 the key to inflammation and fibrosis in hypertensive heart disease? Hypertension. 2010; 55:1088-1089.
186. Zhou Q, Chung AC, Huang XR, Dong Y, Yu X and Lan HY. Identification of novel long noncoding RNAs associated with TGF-beta/Smad3-mediated renal inflammation and fibrosis by RNA sequencing. Amer J Pathol. 2014; 184:409-417.
187. Tichauer JE, Flores B, Soler B, Eugenin-von Bernhardi L, Ramirez G and von Bernhardi R. Age-dependent changes on TGFbeta1 Smad3 pathway modify the pattern of microglial cell activation. Brain Behav Immun. 2014; 37:187-196.
188. Vijayachandra K, Lee J and Glick AB. Smad3 regulates senescence and malignant conversion in a mouse multistage skin carcinogenesis model. Cancer Res. 2003; 63:3447-3452.
189. Dinger ME, Mercer TR and Mattick JS. RNAs as extracellular signaling molecules. J Mol Endocrinol. 2008; 40:151-159.
190. Roberts CT and Kurre P. Vesicle Trafficking and RNA Transfer Add Complexity and Connectivity to Cell-Cell Communication. Cancer Res. 2013; 73:3200-3205.
191. Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ and Lotvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007; 9:654-U672.
192. Kogure T, Yan IK, Lin WL and Patel T. Extracellular Vesicle-Mediated Transfer of a Novel Long Noncoding RNA TUC339: A Mechanism of Intercellular Signaling in Human Hepatocellular Cancer. Genes Cancer. 2013; 4:261-272.
193. Braconi C, Valeri N, Kogure T, Gasparini P, Huang N, Nuovo GJ, Terracciano L, Croce CM and Patel T. Expression and functional role of a transcribed noncoding RNA with an ultraconserved element in hepatocellular carcinoma. Proc Natl Acad Sci USA. 2011; 108:786-791.
194. Li K, Blum Y, Verma A, Liu Z, Pramanik K, Leigh NR, Chun CZ, Samant GV, Zhao B, Garnaas MK, Horswill MA, Stanhope SA, North PE, Miao RQ, et al. A noncoding antisense RNA in tie-1 locus regulates tie-1 function in vivo. Blood. 2010; 115:133-139.
195. Takahashi K, Yan IK, Kogure T, Haga H and Patel T. Extracellular vesicle-mediated transfer of long non-coding RNA ROR modulates chemosensitivity in human hepatocellular cancer. FEBS Open Bio. 2014; 4:458-467.
196. Gezer U, Ozgur E, Cetinkaya M, Isin M and Dalay N. Long non-coding RNAs with low expression levels in cells are enriched in secreted exosomes. Cell Biol Intl. 2014; 38:1076-1079.